Cargando…

Cytoplasmic Her2/neu Immunohistochemical Staining in Breast Cancer; From a Molecular Point of View

Detalles Bibliográficos
Autores principales:	Safaei, Akbar, Monabati, Ahmad, Mokhtari, Maral, Montazer, Mehdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Society of Pathology 2019
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742732/ https://www.ncbi.nlm.nih.gov/pubmed/31583007 http://dx.doi.org/10.30699/ijp.2019.76630.1732

Ejemplares similares

Blastic Plasmacytoid Dendritic Cell Neoplasm; A Report of Three Cases
por: Safaei, Akbar, et al.
Publicado: (2019)

Evaluation of the CD123 Expression and FLT3 Gene Mutations in Patients with Acute Myeloid Leukemia
por: Safaei, Akbar, et al.
Publicado: (2018)

Immune Checkpoint Molecules in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
por: Monabati, Ahmad, et al.
Publicado: (2020)

Prognostic Value of Her2/neu Expression in Gastrointestinal Stromal Tumors: Immunohistochemical Study
por: Abd El-Aziz, Ahmed M, et al.
Publicado: (2017)

A Novel Image Cytometric Method for Quantitation of Immunohistochemical Staining of Cytoplasmic Antigens
por: Guillaud, M., et al.
Publicado: (1997)

HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma
por: Movagharnejad, Kourosh, et al.
Publicado: (2013)

A Rare Chromosomal Abnormality in Chronic Lymphocytic Leukemia: t(13;13)
por: Safaei, Akbar, et al.
Publicado: (2020)

Image Analysis of HER2 Immunohistochemical Staining of Surgical Breast Cancer Specimens
por: Yim, Kwangil, et al.
Publicado: (2019)

The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell/Histiocyte-Rich large B-Cell lymphoma
por: Kosari, Farid, et al.
Publicado: (2022)

Breast Cancer and Her-2/Neu
por: Sherwood, Roy
Publicado: (2005)

The Effects of Low HER2/neu Expression on the Clinicopathological Characteristics of Triple-Negative Breast Cancer Patients
por: Dehghani, Mehdi, et al.
Publicado: (2020)

Association between AgNORs and Immunohistochemical Expression of ER, PR, HER2/neu, and p53 in Breast Carcinoma
por: Ahmed, Hussain Gadelkarim, et al.
Publicado: (2011)

Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study
por: Hussein, Israa A, et al.
Publicado: (2020)

Investigating the Relationship between of Vascular Endothelial Growth Factor and HER-2neu in IHC Staining with Metastasis and Mortality in Patients with Osteosarcoma
por: Aznab, Mozaffar, et al.
Publicado: (2020)

HER-2/neu diagnostics in breast cancer
por: Carney, Walter P, et al.
Publicado: (2007)

The Clinical Importance of the Heterogeneity of HER2 neu
por: Davila, Enrique, et al.
Publicado: (2010)

The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer
por: Lassus, H, et al.
Publicado: (2007)

Label-Free Virtual HER2 Immunohistochemical Staining of Breast Tissue using Deep Learning
por: Bai, Bijie, et al.
Publicado: (2022)

Reply: The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer
por: de Graeff, P, et al.
Publicado: (2007)

HER 2/neu protein expression in colorectal cancer
por: Schuell, B, et al.
Publicado: (2006)

HER-2/neu Testing and Therapy in Gastroesophageal Adenocarcinoma
por: Moelans, Cathy B., et al.
Publicado: (2010)

Anti-HER2/Neu passive-aggressive immunotherapy
por: Mortenson, Eric D, et al.
Publicado: (2014)

HER2/neu testing in primary colorectal carcinoma
por: Ingold Heppner, B, et al.
Publicado: (2014)

Review of the Role of HER2/neu in Colorectal Carcinomas
por: Achalla, Lakshmi Sai Vijay, et al.
Publicado: (2022)

A Rare Case of Extramedullary T/Myeloid Mixed Phenotype Acute Leukemia with t(1;5)(q23;q33)
por: Monabati, Ahmad, et al.
Publicado: (2016)

Additional cytogenetic aberrations in chronic myeloid leukemia: a single-center experience in the Middle East
por: Safaei, Akbar, et al.
Publicado: (2018)

Patterns of Immunohistochemical Expression of P53, BCL2, PTEN, and HER2/neu Tumor Markers in Specific Breast Cancer Lesions
por: Bealy, Mohamed Ahmed, et al.
Publicado: (2022)

Immunohistochemical Profiling of HER-2/neu, Steroid Hormone Receptors and KI-67 Biomarkers in A Cohort of Nigerian Women with Breast Cancer
por: Ayandipo, Omobolaji O., et al.
Publicado: (2023)

Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours.
por: DiGiovanna, M. P., et al.
Publicado: (1996)

Evaluation of Microvessel Density of Hepatocellular Carcinoma and Comparison with Benign Lesions of Liver: An Immunohistochemical Study
por: Amoueian, S, et al.
Publicado: (2012)

Cytoplasmic p21(WAF1/CIP1 )expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis
por: Winters, Zoë E, et al.
Publicado: (2003)

Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8(+) T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice
por: Chen, Y, et al.
Publicado: (2011)

Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
por: Brodowicz, T, et al.
Publicado: (2001)

JAK2, CALR, and MPL Mutation Profiles in BCR-ABL Negative Myeloproliferative Neoplasms, a Referral Center Experience in the Middle East
por: Safavi, Moeinadin, et al.
Publicado: (2021)

Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization
por: Yamashita-Kashima, Yoriko, et al.
Publicado: (2014)

HER-2/neu oncogene: what does amplification mean?
por: Pavy, J. J., et al.
Publicado: (1993)

Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001)

HER2/neu-directed therapy for biliary tract cancer
por: Javle, Milind, et al.
Publicado: (2015)

Expression of HER-2/neu in Oral Squamous Cell Carcinoma
por: Mirza, Sana, et al.
Publicado: (2020)

Expression of Septin 2 and Her2/neu in Colorectal Cancer
por: Hanbuli, Hala M. El, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_01l67jkobq8q0j60qjemtnq8tj